|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
The New Healthy Aging Imperative and What It Means for Pharma
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5